A new USC Schaeffer Center white paper finds expanded access to anti-obesity medications would lead to significant increases ...

GSA is a professional membership organization committed to promoting the best available interdisciplinary aging research to advance innovations in practice and policy. This is especially key to ...

Drugs like Ozempic and Wegovy have the power to block the forces driving obesity, but the knock-on societal effects may not necessarily be so positive ...

New study finds that obesity reduces a specific brain chemical, lowering the desire to consume high-calorie foods. Boosting ...

New research to be presented at the European Congress on Obesity (ECO 2025, Malaga, Spain, 11–14 May) shows an association ...

A new study reveals that long-term high-fat diets reduce pleasure from eating by lowering neurotensin, a brain peptide that ...

Obesity is a growing health concern worldwide, affecting millions of people. It not only impacts physical appearance but also increases the risk of several chronic diseases, including diabetes, heart ...

For the last 2 years, compounded versions of glucagon-like peptide 1 (GLP-1) medications have been big business. Nearly 137 million American adults are eligible to use these costly drugs to treat ...

(Relevance: India is suffering from the double burden of malnutrition and rising obesity. Recently, the Prime Minister also emphasized reducing oil consumption by 10%. He has nominated celebrities to ...

FLORENCE, ITALY — Obesity must be recognized and treated as a disease. This was the central message of the 23rd European Congress of Internal Medicine (ECIM), held from March 5 to 8, 2025.

Our health is the most important thing when it comes to our bodies, and what “healthy” looks like can vary for each person. While discussions about weight can be a sensitive subject, it is important ...